ACLX · As filed with the SEC

Arcellx cash flow statement, by fiscal year

The statement as Arcellx presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF CASH FLOWS · USD

USDFY2025
Year ended Dec 31, 2025
FY2024
Year ended Dec 31, 2024
FY2023
Year ended Dec 31, 2023
FY2022
Year ended Dec 31, 2022
Cash flows from operating activities
Net loss(228,934,000)(107,348,000)(70,690,000)(188,679,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization6,678,0005,188,0002,040,0001,321,000
Loss on disposal of property and equipment82,000(260,000)174,0003,000
Noncash operating lease expense—3,310,0001,010,000903,000
Noncash operating lease expense(38,000)———
Right of use asset expensed0794,00018,871,00063,278,000
Amortization of premiums and discounts on marketable securities(8,443,000)(15,459,000)(11,048,000)(2,125,000)
Share-based compensation77,891,00061,086,00041,789,00021,544,000
Changes in operating assets and liabilities:
Prepaid expenses and other current and non-current assets(2,211,000)8,611,000(8,359,000)(5,695,000)
Accounts payable and other current liabilities2,664,000(70,000)(6,474,000)7,419,000
Accrued liabilities(21,437,000)42,009,0005,593,000(395,000)
Operating lease liabilities(1,931,000)(3,767,000)13,461,0003,123,000
Contract liability to related party(25,986,000)(86,154,000)221,206,000—
Other non-current liabilities(8,593,000)8,593,000——
Net cash provided by (used in) operating activities(210,258,000)(83,467,000)207,573,000(99,303,000)
Cash flows from investing activities
Purchases of property and equipment(2,327,000)(13,434,000)(21,428,000)(2,277,000)
Purchases of marketable securities(406,976,000)(597,311,000)(442,429,000)(273,737,000)
Proceeds from maturities of marketable securities495,600,000427,700,000309,345,000158,340,000
Net cash provided by (used in) investing activities86,297,000(183,045,000)(154,512,000)(117,674,000)
Cash flows from financing activities
Proceeds from issuance of common stock in private placement, net of transactions costs0—299,706,0009,958,000
Proceeds from issuance of common stock in offerings, net of issuance costs131,562,000——129,156,000
Proceeds from exercise of stock options4,321,000———
Proceeds from issuance of common stock (follow-on offering), net of transactions costs———120,719,000
Proceeds from exercise of stock options and early exercise of restricted stock—14,595,0007,758,0002,467,000
Proceeds from issuance of common stock under the employee stock purchase plan1,303,0001,164,0001,091,000—
Payments under finance leases(230,000)(39,846,000)(29,392,000)(9,675,000)
Tax withholding payments related to net share settlement of restricted stock units(38,422,000)———
Net cash provided by (used in) financing activities98,534,000(24,087,000)279,163,000252,625,000
Net increase (decrease) in cash and cash equivalents and restricted cash(25,427,000)(290,599,000)332,224,00035,648,000
Cash and cash equivalents and restricted cash, beginning of the year108,305,000398,904,00066,680,00031,032,000
Cash and cash equivalents and restricted cash, end of the year82,878,000108,305,000398,904,00066,680,000
Supplemental disclosures of cash flow information:
Cash paid for income taxes1,319,0001,635,000212,000—
Supplemental disclosures of noncash investing and financing activities:
Purchase of property and equipment included in accounts payable and accrued liabilities944,000325,0001,841,000770,000

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.